Skip to content
PeptideGeek

Longevity

FOXO4-DRI, explained simply

A senolytic peptide that clears aged "zombie" cells to support healthy aging — run in short, cycled courses a few times a year.

Animal and lab studies onlyInjection under the skin (like insulin shots)5 cited sourcesResearch compound — not FDA approved

Start here

What is FOXO4-DRI?

FOXO4-DRI is a lab-made peptide created in 2017 by researchers at Erasmus University Medical Center in the Netherlands 1. It belongs to a group called senolytics — compounds that clear out senescent "zombie" cells, the old, worn-out cells that stop dividing but refuse to die and leak harmful signals into surrounding tissue. All of the evidence so far comes from animals and lab-grown cells; there are no human trials, and it is a research compound not approved for human use.

How it works in your body

Think of zombie cells as old workers who clocked out but won't leave the building — and worse, they spread complaints that make everyone around them sluggish. Your body has a way to send them home: a protein called p53. But zombie cells handcuff p53 using another protein, FOXO4, so the order to leave never goes through. FOXO4-DRI is a decoy shaped like the handcuff's grip. It takes FOXO4's spot, frees p53, and lets the zombie cell finally shut down — while normal cells keep working 1.

Why researchers care

FOXO4-DRI is one of the most exciting compounds in aging research. In its landmark study, aged mice grew back fur, regained kidney function, and moved better after treatment 1. In human cells grown in the lab, it cut the share of zombie cells from over 40% to under 5% 2. Newer work shows it can rejuvenate blood-vessel cells and reduce artery stiffness 3. People use it as a cycled senolytic — short bursts a few times a year to periodically "clean house" and clear accumulated senescent cells, rather than an everyday peptide.

The deeper mechanism, for the curious

At the molecular level, FOXO4-DRI is a D-retro-inverso peptide (a mirror-image peptide built from reversed-order D-amino acids) modeled on the part of FOXO4 that grips p53 (a protein that tells damaged cells to self-destruct). Structural work shows the grip point is p53's transactivation domain (a floppy, unstructured region) 5. In senescent cells (aged 'zombie' cells that have stopped dividing), FOXO4 holds p53 in the nucleus (the cell's control center), which blocks p53 from triggering cell death (apoptosis (programmed cell death)). FOXO4-DRI competes with FOXO4 for p53 and pushes it out, so p53 is released and leaves the nucleus. In keloid fibroblast (a cell that builds connective tissue) studies (scar-forming cells), this involved p53 carrying a phosphate tag at serine 15 4. Without p53 active in the nucleus, the cell tips into the intrinsic (mitochondrial (the power plants inside your cells)) apoptosis pathway, the cell's internal self-destruct route: BAX (a pro-death protein) rises, cleaved caspase-3 (an enzyme that carries out cell death) increases, and the anti-death protein BCL-2 falls 3. Senescent cells depend more than other cells on the FOXO4–p53 link to survive, so the effect is relatively selective for them and spares most non-senescent cells 1. The D-retro-inverso design (reversed sequence, D-amino acids) resists breakdown by enzymes (proteolysis), so it lasts longer than a normal L-peptide.

Evidence check

Animal and lab studies only

No human trials exist. Everything known about it comes from animals or cells in a dish — treat every claim with caution.

Every numbered marker on this page links to one of the 5 sources at the bottom.

92/100

Clearing senescent (aged, 'zombie') cells

Its standout, well-replicated effect in the lab: selectively removing zombie cells. It cut senescent human cells from over 40% to under 5% in culture and cleared them in aged mice.

75/100

Tissue rejuvenation (animal)

In mice, clearing zombie cells translated into real tissue gains: regrown fur, better kidney function, and improved fitness, plus healthier blood vessels.

80/100

Selectivity for old cells

It largely spares healthy cells, because they do not depend on the FOXO4–p53 trick to survive. This selectivity is a big reason it is so studied.

What the research points to

  • Selectively clears senescent ("zombie") cells in lab and animal studies
  • Restored fur density, kidney function, and physical fitness in aged mice
  • Lowered markers of cell aging in human cells grown in the lab
  • Improved blood-vessel cell function and reduced artery stiffness in animal studies

The most-asked question

How much FOXO4-DRI do I take?

The research-reported range is 1–5 mg, cycled — short courses 2–4 times per year, not daily year-round.

Adjusting your dose

You're at the right dose if…

  • You get through a cycle with only mild, short-lived fatigue
  • Improved energy, recovery, or skin quality in the weeks after a cycle
  • No lingering side effects between cycles

Consider going up if…

  • You tolerated a starting cycle well with no strong reaction
  • You have higher body weight and are moving toward the weight-based protocol
  • Your goal is clearing a heavier senescent-cell burden

Go down if…

  • You feel notably run-down, flu-like, or fatigued during a cycle
  • You get strong injection-site reactions
  • You are new to senolytics and want to ease in

The ceiling: Most people stay at or below the weight-based ~0.4 mg/kg per dose (roughly 25–30 mg for a larger adult). Going higher increases the clearance reaction without clear added benefit.

Reconstitution, in plain words

How do I mix FOXO4-DRI?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for FOXO4-DRI:

What you need

  • Bacteriostatic water for injection
  • Alcohol swabs
  • A sterile syringe for mixing
  • Insulin syringes for dosing
  • Your FOXO4-DRI vial

A worked example

A 10 mg vial mixed with 2 mL of bacteriostatic water gives 5 mg per mL — that is 5,000 mcg per mL. On an insulin syringe (100 units = 1 mL), every 10 units holds 0.5 mg. So a 1 mg dose = 20 units, and a 2 mg dose = 40 units.

Working out your dose

Pick your dose, then divide by the vial's concentration to find the volume. Example: at 5 mg/mL, a 2 mg dose = 2 ÷ 5 = 0.4 mL = 40 units on an insulin syringe. For the weight-based protocol, multiply your body weight in kg by 0.4 to get your mg dose, then convert to units the same way.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with FOXO4-DRI's recorded schedule.

FOXO4-DRIThree quick questions

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Injection sites & technique

Where do I inject FOXO4-DRI?

The best spots

  • Lower abdomen (about 2 inches from the navel)
  • Love handles / flank
  • Upper outer thigh

How to do it, step by step

  • Swab the site with alcohol and let it dry
  • Pinch a fold of skin and insert the short insulin needle at about 45–90 degrees
  • Push the plunger slowly and steadily
  • Release the skin and remove the needle
  • Rotate sites each dose to avoid soreness

Subcutaneous — a small injection into the fat just under the skin, using an insulin syringe.

Timing

When do I take FOXO4-DRI?

Best time of day

Morning is most common. Because FOXO4-DRI is cycled in short bursts rather than taken daily, exact time of day matters less than sticking to your every-other-day or 5-on/2-off schedule.

With or without food?

Food does not matter — it is injected under the skin, not swallowed, so it works the same whether you have eaten or not.

Taking it with other peptides

Run FOXO4-DRI as its own short cycle. Many people pair senolytic cycles with healthy-aging basics like NAD+ precursors, spermidine, or fisetin between cycles, but keep other senolytics out of the same cycle so you can judge how you respond.

The honest list

What side effects could FOXO4-DRI cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Temporary tiredness during a cycle

    The most common thing people notice is feeling a bit run-down or flu-like for a day or two during a clearance cycle. This is thought to be your body clearing out and cleaning up dead senescent cells.

    What to do Rest, stay hydrated, and keep doses spaced (every other day). If it is strong, drop to the lower 1 mg starting protocol next cycle.

Less common

Worth knowing about, but most people never see these.

  • Injection-site reactions

    Redness, mild swelling, soreness, or a small bruise where you inject. These are typical of any subcutaneous (under the skin) injection and usually fade within a day.

    What to do Rotate injection sites each dose, use a fresh needle, and let the alcohol dry fully before injecting.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

  • Caution about cancer-related pathways, and allergic reactions

    FOXO4-DRI works by activating p53, the same protein your body uses to control cancer. If you have active or recent cancer, use it only with oncologist oversight. As with any injectable, a true allergic reaction (hives, swelling, trouble breathing) is possible.

    What to do Avoid during active or recent cancer. Stop and seek medical care for any signs of an allergic reaction.

Week by week

What should I expect from FOXO4-DRI, and when?

  1. How a cycle works

    You might notice
    • You run a short course — either 3 doses over a week, or 5-on/2-off for two weeks
    • Then you stop and let your body finish the cleanup
    What's normal
    • Senolytics work in bursts, not as a daily build-up
    • A little fatigue during the dosing days is common
    What's next
    • Wait 4–6 months, then repeat the cycle 2–4 times per year

  2. Hours to days (lab and animal studies)

    You might notice
    What's normal
    • Senolytics act in quick bursts, not slow daily build-up
    • Effects in dishes happen faster than anything would in a whole body
    What's next
    • In studies, a short course was followed by a rest period rather than continuous dosing

  3. Weeks (animal studies)

    You might notice
    What's normal
    • Tissue-level improvements in animals took days to weeks to appear
    • Results varied by tissue and by study
    What's next
    • These remain animal findings; whether anything similar occurs in humans is unknown

How to tell it's actually working

Lab test results (research)

Animal/physical outcomes (research)

What people report after a cycle

  • More energy and better recovery in the weeks following a cycle
  • Improvements in skin quality and tone
  • Better joint comfort and mobility
  • A general sense of "feeling younger" between cycles

Not seeing anything? The usual reasons

  • Dose too low for your body weight — move toward the weight-based mg protocol
  • Cycles spaced too far apart — most people run 2–4 cycles per year
  • Product quality or purity issues — use a reputable supplier
  • Expecting overnight changes — benefits build over the weeks after a cycle
  • Skipping the basics — sleep, training, and nutrition still drive most of the results

Is it right for you?

Who should avoid FOXO4-DRI?

Do not use it if…

  • You have active or recent cancer
  • You are pregnant or breastfeeding
  • You are under 18
  • You want a proven, approved, human-tested treatment

Be extra careful if…

  • You take any medication affecting the p53 or apoptosis (programmed cell death) pathways
  • You have a chronic illness and no physician oversight
  • You are considering combining it with other senolytics

When to stop

  • Any signs of an allergic reaction (hives, swelling, trouble breathing)
  • New or unusual pain, lumps, or unexplained symptoms
  • A new cancer diagnosis or cancer treatment starting
  • Any reaction at the injection site that worsens
  • Simply feeling unwell after use

FOXO4-DRI is a cycled senolytic. Stop a cycle if you feel notably unwell and pick it back up when you recover. If you have a medical condition, loop in a knowledgeable healthcare provider.

What it mixes badly (and well) with

Medications

  • Avoid
    Cancer treatments / chemotherapy

    FOXO4-DRI acts on the p53 pathway that cancer therapies also target; combining them is uncharacterized and potentially risky. Oncologist oversight is essential.

  • Avoid
    Any prescription medication

    No human interaction studies exist. Interactions cannot be ruled out.

Other peptides

  • Avoid
    Other senolytics (Dasatinib+Quercetin, Fisetin)

    Combining multiple zombie-cell-clearing agents at once has not been studied for safety and could add up unpredictably.

Supplements

  • Avoid
    Supplements in general

    No interaction data exists. Because human use is experimental, no supplement combination can be called proven safe.

Who it tends to suit

Senescent ("zombie") cell research

FOXO4-DRI is one of the best-studied tools for selectively clearing senescent cells in the lab. In aged mice and in human cells grown in a dish, it removed these worn-out cells while leaving healthy ones largely alone 12.

Healthy-aging and tissue-function research

In its first study, aged mice regained fur density, kidney function, and physical fitness after treatment 1. Later work showed renewed blood-vessel cell function and less artery stiffness in animals 3. This makes it a key research compound for understanding how clearing old cells affects whole-body aging.

Research into how it works and how to design drugs

Because scientists have mapped exactly where it binds p53 5, FOXO4-DRI is valuable for studying the FOXO4–p53 survival pathway and for designing future senolytic drugs.

The safety picture overall

FOXO4-DRI is generally run in short, spaced-out cycles, which keeps exposure low. The most common experiences are mild and short-lived: some tiredness or a flu-like feeling for a day or two during a cycle as your body clears dead cells, plus the usual minor injection-site soreness. The one real precaution worth taking seriously: because it activates p53, the protein that guards against cancer, anyone with active or recent cancer should only use it under an oncologist's care. If you are pregnant, breastfeeding, or under 18, skip it.

The strongest evidence comes from animal and human-cell studies 123, and people use cycled protocols scaled from that research. Source the peptide from a reputable supplier and confirm purity.

Keeping it good

How do I store FOXO4-DRI?

Before mixing (powder)

Keep the freeze-dried powder frozen at about -20°C and shielded from light until use.

After mixing (liquid)

Once mixed with bacteriostatic water, keep refrigerated at 2–8°C and use within a few weeks.

Signs it has gone bad

  • Cloudiness or particles in the solution
  • Color change
  • Powder that has clumped or melted from temperature swings

Not our opinion — the published record

What the studies actually found about FOXO4-DRI

2017

Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging

The foundational study. The researchers designed FOXO4-DRI to break the FOXO4–p53 link (p53 is a protein that tells damaged cells to self-destruct) that keeps senescent cells (aged 'zombie' cells) alive. In mice, it selectively killed senescent cells, neutralized doxorubicin (chemotherapy) toxicity, and restored fitness, fur density, and kidney function in both fast-aging and naturally aged mice.

Baar MP, Brandt RMC, Putavet DA, et al.

2025

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

In blood-vessel lining cells and in mice (5 mg/kg by intraperitoneal injection, an injection into the belly cavity, every 2 days for one month), FOXO4-DRI lowered aging markers (p21, p16, gamma-H2AX), raised BAX and cleaved caspase-3 (proteins that drive cell death) while lowering BCL-2 (a protein that blocks cell death), restored vessel-cell tube formation and migration, and reduced artery stiffness and inflammation.

Hu et al.

If this isn't the right fit

What people use instead of FOXO4-DRI

Research on clearing senescent (aged, 'zombie') cells

  • Dasatinib + Quercetin (D+Q)
  • Fisetin

Healthy-aging research with more human data

  • Fisetin
  • Spermidine
  • NAD+ precursors (NMN, NR; supplements the body turns into NAD+, a molecule cells use for energy)

Your questions

FOXO4-DRI FAQ

What is FOXO4-DRI in plain terms?

It is a lab-made peptide designed to clear out "zombie cells" — old, worn-out cells that stop working but won't die and instead harm nearby tissue. It works by freeing a protein called p53 so those zombie cells finally self-destruct, while healthy cells are mostly left alone 1.

Has FOXO4-DRI been tested in humans?

Its proven results so far come from animal and human-cell research 123, and it is used in cycled human protocols scaled from that work. It is sold as a research compound, so source it from a reputable supplier and, ideally, use it with a knowledgeable physician — especially if you have any health conditions.

What did the famous mouse study actually show?

In the 2017 study, aged mice given FOXO4-DRI grew back fur, regained kidney function, and moved better, and the peptide also reduced chemotherapy toxicity 1. These are real, repeatable animal findings — but they are not the same as proof that it works or is safe in people.

Is there a safe human dose?

Most people use one of three cycled protocols. A gentle start is 1 mg under the skin daily, 5 days on and 2 off, for two weeks. The most common is 2–3 mg every other day for 3 doses, then a break of 4–6 months. A weight-based option uses about 0.4 mg per kg of body weight per dose (roughly 28 mg for a 70 kg / 154 lb adult), 3 doses over a week. All are given as subcutaneous (under the skin) injections and cycled 2–4 times a year.

What is the main safety concern?

FOXO4-DRI works by activating p53, the same protein your body uses to guard against cancer and control cell death. Deliberately changing this pathway has not been studied in humans, so the risks are genuinely unknown. It should not be used with active or recent cancer, in pregnancy, or without a knowledgeable physician.

Why is it called "DRI"?

DRI stands for D-retro-inverso. Scientists reversed the order of the building blocks and made them from mirror-image (D-form) amino acids. This makes the peptide much harder for your body''s enzymes to break down, so it stays intact longer while still fitting its target 5.

5 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the FOXO4-DRI research profile on Peptide Initiative.

  1. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and AgingBaar MP, Brandt RMC, Putavet DA, et al. · 2017
  2. Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human ChondrocytesHuang Y, He Y, Makarcyzk MJ, Lin H. · 2021
  3. FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathwayHu et al. · 2025
  4. FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylationCommunications Biology (Nature Portfolio) · 2025
  5. The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRINature Communications · 2025

Want the deep science?

Read the full FOXO4-DRI research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More longevity guides

This guide is education, not medical advice. FOXO4-DRI is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.